This association was observed in other studies, as described by Gershoni-Baruch et al., (1999), in which 45% of patients with a germline mutation (BRCA1/BRCA2) and positive family history were diagnosed with bilateral breast cancer (14/31). This evidence concerns the gene BRCA2 and breast cancer.